Study of AZD4956 as Monotherapy and in Combination with Anti-Cancer Agents in Participants with Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

Trial Identifier: D8570C00001
Sponsor: AstraZeneca
Start Date: March 2026
Primary Completion Date: March 2030
Study Completion Date: March 2030
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Melbourne, AU, 3000
AU Westmead, AU, 2145
ES Barcelona, ES, 8035
ES Barcelona, ES, 08036
ES Barcelona, ES, 08023
ES Logroño, ES, 26006
ES Pozuelo de Alarcon, ES, 28223
ES Sevilla, ES, 41013
GB London, GB, SE1 9RT
GB Sutton, GB, SM25PT
JP Chuo-ku, JP, 104-0045
JP Kashiwa, JP, 277-8577
KR Seoul, KR, 03080
KR Seoul, KR, 120-752
US, NY New York, NY, US, 10065
US, RI Providence, RI, US, 02903
US, TX Houston, TX, US, 77030
US, VA Fairfax, VA, US, 22031